JL 2025 family trust LLC plans to sell 8,382 Hinge Health Class A shares valued at approximately $754,380. The trust is identified as a 10% stockholder, and the transaction gives investors a specific view of a proposed sale by a significant holder.
Key Highlights
- The trust’s proposed transaction covers 8,382 Hinge Health Class A shares valued at approximately $754,380.
- JL 2025 Family Trust LLC is identified as a 10% stockholder of Hinge Health.
- Melissa Fisher signed as authorized representative for Raymond James & Associates, acting as attorney-in-fact for the trust.
Hinge Health, Inc. (NYSE: HNGE) 10% stockholder JL 2025 Family Trust LLC filed to sell 8,382 Class A shares valued at approximately $754,380. The trust’s listed securities position is 62,468,721 Class A shares.
Proposed Trust Share Sale
The proposed sale covers 8,382 shares. The stated aggregate value is $754,380, also described as approximately $754,380. The filing includes the date 09/01/2026.
Distribution From Insight Entities
The filing lists an in-kind distribution from various Insight entities dated 08/10/2026. The record identifies Insight Venture Partners N as part of that distribution information.
Listed Class A Position
Hinge Health’s Class A securities are listed on the NYSE under HNGE. The transaction record identifies the company’s address as 455 Market Street, 7th Floor, San Francisco, California 94,105.
Peers Moving on This News
FAQs
Q: How many Hinge Health shares did JL 2025 Family Trust file to sell?
A: JL 2025 Family Trust LLC filed a Form 144 to sell 8,382 Hinge Health Class A shares. The filing states an aggregate value of approximately $754,380.
Q: How is JL 2025 Family Trust identified in the filing?
A: The filing identifies JL 2025 Family Trust LLC as a 10% stockholder of Hinge Health. Raymond James & Associates is listed as the broker.
Q: What distribution information appears in the filing?
A: The filing lists an in-kind distribution from various Insight entities dated August 10, 2026. It identifies Insight Venture Partners N in that information.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.